Cargando…

A computerized Infusion Pump for control of tissue tracer concentration during Positron Emission Tomography in vivo Pharmacokinetic/Pharmacodynamic measurements

BACKGROUND: A computer controlled infusion pump (UIPump) for regulation of target tissue concentration of radioactive compounds was developed for use in biological research and tracer development for PET. METHODS: Based on observed tissue or plasma kinetics after a bolus injection of the tracer an a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eriksson, Olof, Wallberg, Andreas, Syvänen, Stina, Josephsson, Raymond, Långström, Bengt, Bergström, Mats
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2430701/ https://www.ncbi.nlm.nih.gov/pubmed/18513382 http://dx.doi.org/10.1186/1756-6649-8-2

Ejemplares similares

Assessment of receptor occupancy-over-time of two dopamine transporter inhibitors by [(11)C]CIT and target controlled infusion
por: Eriksson, Olof, et al.
Publicado: (2011)

Application of the multicellular tumour spheroid model to screen PET tracers for analysis of early response of chemotherapy in breast cancer
por: Monazzam, Azita, et al.
Publicado: (2007)

A new, fast and semi-automated size determination method (SASDM) for studying multicellular tumor spheroids
por: Monazzam, Azita, et al.
Publicado: (2005)

First-in-class positron emission tomography tracer for the glucagon receptor
por: Velikyan, Irina, et al.
Publicado: (2019)

Early astrocytosis in autosomal dominant Alzheimer’s disease measured in vivo by multi-tracer positron emission tomography
por: Schöll, Michael, et al.
Publicado: (2015)

Synthesis of two potential NK(1)-receptor ligands using [1-(11)C]ethyl iodide and [1-(11)C]propyl iodide and initial PET-imaging
por: Syvänen, Stina, et al.
Publicado: (2007)

Multicellular Tumour Spheroid as a model for evaluation of [(18)F]FDG as biomarker for breast cancer treatment monitoring
por: Monazzam, Azita, et al.
Publicado: (2006)

Pharmacokinetics and Pharmacodynamics of the Proton Pump Inhibitors
por: Shin, Jai Moo, et al.
Publicado: (2013)

Performance of Principal Component Analysis and Independent Component Analysis with Respect to Signal Extraction from Noisy Positron Emission Tomography Data - a Study on Computer Simulated Images
por: Razifar, Pasha, et al.
Publicado: (2009)

Impact of Computerized Order Entry to Pharmacy Interface on Order-Infusion Pump Discrepancies
por: Russell, Rebecca A., et al.
Publicado: (2015)

Tau Filaments and the Development of Positron Emission Tomography Tracers
por: Goedert, Michel, et al.
Publicado: (2018)

Pharmacokinetic modeling of P-glycoprotein function at the rat and human blood–brain barriers studied with (R)-[(11)C]verapamil positron emission tomography
por: Müllauer, Julia, et al.
Publicado: (2012)

Novel Positron Emission Tomography Tracers for Imaging Vascular Inflammation
por: Ćorović, Andrej, et al.
Publicado: (2020)

Proton Pump Inhibitors in Pediatrics: Mechanism of Action, Pharmacokinetics, Pharmacogenetics, and Pharmacodynamics
por: Ward, Robert M., et al.
Publicado: (2013)

1547. Modeling Pharmacokinetics and Pharmacodynamics of Meropenem Utilizing a Novel Infusion Method of Bolus to Prolonged Infusion
por: Moore, Sarah E, et al.
Publicado: (2019)

Recent Developments in Positron Emission Tomography Tracers for Proteinopathies Imaging in Dementia
por: Ni, Ruiqing, et al.
Publicado: (2022)

Tracers progress for positron emission tomography imaging of glial-related disease
por: Jia, Haoran, et al.
Publicado: (2022)

Population pharmacokinetic‐pharmacodynamic analyses of amyloid positron emission tomography and plasma biomarkers for lecanemab in subjects with early Alzheimer's disease
por: Hayato, Seiichi, et al.
Publicado: (2022)

Head-to-head comparison of tau positron emission tomography tracers [(18)F]flortaucipir and [(18)F]RO948
por: Smith, Ruben, et al.
Publicado: (2019)

Positron emission tomography/computerized tomography imaging of multiple focus of neurolymphomatosis
por: Peterson, James, et al.
Publicado: (2014)

Insight into the Binding of First- and Second-Generation PET Tracers to 4R and 3R/4R Tau Protofibrils
por: Li, Junhao, et al.
Publicado: (2023)

Pharmacokinetic/Pharmacodynamic Evaluation of Dexlansoprazole Infusion Injection Compared with Lansoprazole in Healthy Chinese Adults
por: Wu, Lihua, et al.
Publicado: (2019)

Compelling Case for Fostering Titanium-45 for Positron Emission Tomography Tracer Applications
por: Ramamoorthy, Natesan
Publicado: (2020)

Contribution of Different Positron Emission Tomography Tracers in Glioma Management: Focus on Glioblastoma
por: Moreau, Aurélie, et al.
Publicado: (2019)

Positron emission tomography imaging of lung cancer: An overview of alternative positron emission tomography tracers beyond F18 fluorodeoxyglucose
por: Zhu, Jing, et al.
Publicado: (2022)

Masked volume wise principal component analysis of small adrenocortical tumours in dynamic [11C]-metomidate positron emission tomography
por: Razifar, Pasha, et al.
Publicado: (2009)

Pharmacokinetics and Pharmacodynamics of Meropenem by Extended or Continuous Infusion in Low Body Weight Critically Ill Patients
por: Luque, Sonia, et al.
Publicado: (2021)

Non-isotropic noise correlation in PET data reconstructed by FBP but not by OSEM demonstrated using auto-correlation function
por: Razifar, Pasha, et al.
Publicado: (2005)

Autoradiography screening of potential positron emission tomography tracers for asymptomatic abdominal aortic aneurysms
por: Tegler, Gustaf, et al.
Publicado: (2014)

Discordant findings of different positron emission tomography/CT tracers in a case of glioblastoma
por: Kumar, Ram Elumalai, et al.
Publicado: (2021)

Pharmacokinetics and Pharmacodynamics of Posaconazole
por: Chen, Lu, et al.
Publicado: (2020)

Pharmacokinetics and Pharmacodynamics of Ibrexafungerp
por: McCarthy, Matthew William
Publicado: (2021)

Pharmacokinetics and Pharmacodynamics of Tedizolid
por: Iqbal, Khalid, et al.
Publicado: (2022)

To Evaluate the Role of Positron Emission Tomography-Computerized Tomography in Initial Staging of Carcinoma Breast
por: Kansal, Anju, et al.
Publicado: (2021)

Prediction of exposure-driven myelotoxicity of continuous infusion 5-fluorouracil by a semi-physiological pharmacokinetic–pharmacodynamic model in gastrointestinal cancer patients
por: Arshad, Usman, et al.
Publicado: (2020)

Safety, pharmacokinetics, and pharmacodynamics of 4-hour intravenous infusion of eritoran tetrasodium in healthy Japanese and Caucasian males
por: Okubo, Y, et al.
Publicado: (2011)

Pharmacokinetics, pharmacodynamics, and safety of clevidipine after prolonged continuous infusion in subjects with mild to moderate essential hypertension
por: Smith, William B., et al.
Publicado: (2012)

In Vivo Pharmacokinetics/Pharmacodynamics of Cefquinome in an Experimental Mouse Model of Staphylococcus Aureus Mastitis following Intramammary Infusion
por: Yu, Yang, et al.
Publicado: (2016)

General Purpose Pharmacokinetic-Pharmacodynamic Models for Target-Controlled Infusion of Anaesthetic Drugs: A Narrative Review
por: Vandemoortele, Ophélie, et al.
Publicado: (2022)

Pharmacokinetic/Pharmacodynamic Determination of Systemic MIC Breakpoints for Intermittent, Extended, and Continuous Infusion Dosage Regimens of Mecillinam
por: Koumaki, Vasiliki, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vi50b17g3l0ks97v1svhcvli9d